Hospital Virgen del Camino

Sanlúcar de Barrameda, Cádiz 11540

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Diseases, Dyslipidemia, Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes Mellitus, Type2 Diabetes

Studies at this site

• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities — Running, not enrolling
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early